MedTrace Logo

Clinical Performance Evaluation of DxN CMV Assay

NCT03127787 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2018-07-12

No results posted yet for this study

Summary

The DxN Cytomegalovirus (CMV) assay is an in vitro diagnostic assay intended as an aid in the management of CMV-infected individuals undergoing antiviral therapy. the purpose of the study is to establish the clinical performance of the DxN CMV Assay for plasma samples in the intended use population.

Conditions

  • Cytomegalovirus

Interventions

DIAGNOSTIC_TEST

CMV Assay

Molecular diagnostic test to detect CMV

Sponsors & Collaborators

  • Beckman Coulter, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-08-30
Completion
2017-08-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03127787 on ClinicalTrials.gov